Product Availability Update

Promega Manufacturing and Delivery Systems continue to be fully operational during the COVID-19 outbreak. Our teams are in regular contact with suppliers and distributors worldwide and are taking all steps necessary to address both demands for diagnostic tools and reliable delivery of all products as quickly as possible. Learn more

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

NanoLuc™: A Smaller, Brighter and More Stable Luciferase Reporter

Part # PS155


Brock Binkowski, Mary Hall, Braedy Butler, Matt Robers, James Unch*, Kris Zimmerman, Paul Otto, Gedi Vidugiris, Monika Wood, Mike Slater, Lance Encell, Frank Fan and Keith Wood
Promega Corporation, 2800 Woods Hollow Rd Madison, WI 53711; *Promega BioSciences

NanoLuc™ (Nluc) is an ATP-independent luciferase that utilizes a novel coelenterazine analog (furimazine) to produce high intensity, glow-type luminescence. The enzyme, evolved from a deep-sea shrimp, is much brighter than firefly luciferase (Fluc) and provides superior sensitivity as a genetic reporter. It exhibits greater physical stability, which reduces compound interference in high-throughput screening (HTS). NanoLuc™ may be configured for intracellular or secreted reporter formats, and being less than 1/3 the size of Fluc, it is well suited for experiments requiring small reporters (e.g., viral genomes, protein fusions, etc.).

Printed in USA.